Insights

Gathering insights about imed…

Similar companies to imed

imed Tech Stack

imed uses 8 technology products and services including Facebook Pixel, SQL, git, and more. Explore imed's tech stack below.

Facebook Pixel
Analytics
SQL
Database
git
Development
Google Fonts API
Font Scripts
Microsoft Azure
Platform As A Service
Node.js
Programming Languages
CivicTheme
UI Frameworks
Radix UI
UI Frameworks

Media & News

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
MATAWAN, N.J. & MOSCOW, Idaho--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new collaboration with the University of Idaho College of Business and Economics, beginning in the Spring 2026 semester. The initiative connects student teams with real-world biopharma business development projects, reinforcing Apimeds' commitment to fostering innovation, leadership, and discovery across the he.
Nov 10, 2025 | www.businesswire.com
Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business
MATAWAN, N.J. & EUGENE, Ore.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (“Apimeds”) today announced the expansion of the Apimeds ai² Futures Lab program through a new collaboration with the University of Oregon's Lundquist College of Business, starting with the Winter 2026 quarter. The initiative connects student teams with real-world biopharma business development projects, reinforcing Apimeds' commitment to fostering innovation, leadership, and discovery across the health.
Oct 14, 2025 | www.businesswire.com
Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the University of San Diego's Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business leaders for the biopharmaceutical industry. Future Labs is part of Apimeds' ai² innovation.
Sep 15, 2025 | www.businesswire.com
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) today welcomed the U.S. Food and Drug Administration's (FDA) newly released draft guidance on the development of non-opioid pain therapies, highlighting its potential to accelerate the company's lead program, Apitox, for chronic osteoarthritis pain. The draft guidance, entitled “Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance for Industry”, can be found here: https://www.fda.gov/regulatory-inform.
Sep 11, 2025 | www.businesswire.com
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of Alabama Culverhouse College of Business's STEM Path to the MBA program. The initiative aims to identify important assets critical to improving human health and to cultivate the next generation of pharmaceutical industry business leaders. Future Labs is part of Apimeds' ai² innovation platform, connectin.
Aug 25, 2025 | www.businesswire.com
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered, bee venom-based therapeutic, today announced two key additions to its executive leadership team. Susan Kramer, DrPH, has been appointed Senior Vice President of Development, and Brian Peters has joined as Head of the Company's proprietary ai²™ division. Dr. Kramer brings more than 30 year.
Jul 15, 2025 | www.businesswire.com
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects, today announced the closing of its initial public offering (the “Offering”) of 3,375,000 shares of common stock at a public offering price of $4.00 per share. The shares began trading on the NYSE American on May 9, 2025, under the symbol “APUS.”
May 12, 2025 | www.globenewswire.com

imed's Email Address Formats

imed uses at least 2 format(s):

imed Email Formats	Example	Percentage
FLast@i-med.cl	JDoe@i-med.cl	99%
First@i-med.cl	John@i-med.cl	1%
FLast@imed.cl	JDoe@imed.cl	100%

Frequently Asked Questions

Where is imed's headquarters located?

imed's main headquarters is located at Av. Providencia 1760, piso #7, Providencia Santiago, Región Metropolitana 7500503, CL. The company has employees across 6 continents, including South AmericaNorth AmericaAsia.

What is imed's stock symbol?

imed is a publicly traded company; the company's stock symbol is APUS.

What is imed's official website and social media links?

imed's official website is imed.cl and has social profiles on LinkedIn.

What is imed's NAICS code?

imed's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does imed have currently?

As of October 2025, imed has approximately 439 employees across 6 continents, including South AmericaNorth AmericaAsia. Key team members include Chief Information Security Officer (ciso): W. B. S.Chief Technology Officer: M. R.Chief Commercial Officer Latam: C. A.. Explore imed's employee directory with LeadIQ.

What industry does imed belong to?

imed operates in the IT Services and IT Consulting industry.

What technology does imed use?

imed's tech stack includes Facebook PixelSQLgitGoogle Fonts APIMicrosoft AzureNode.jsCivicThemeRadix UI.

What is imed's email format?

imed's email format typically follows the pattern of FLast@i-med.cl. Find more imed email formats with LeadIQ.

When was imed founded?

imed was founded in 2002.

imed

IT Services and IT ConsultingChile201-500 Employees

Somos una empresa del futuro, los primeros en conectar a todas las personas en sus atenciones de salud. 

Desde 2002 conectamos a pacientes, prestadores y financiadores, facilitando los procesos por medio de servicios sustentables y de excelencia basados en tecnología, innovación, eficiencia y confianza.

Si tienes dudas sobre nuestros servicios, entra a nuestro sitio web e ingresa a la sección "Ayuda" que encontrarás en la parte superior derecha.

Company Overview

Headquarters: Av. Providencia 1760, piso #7, Providencia Santiago, Región Metropolitana 7500503, CL
Website: imed.cl
Stock Symbol: APUS
NAICS Code: 5415 - Computer Systems Design and Related Services
Founded: 2002
Employees: 201-500

Media & News

Funding & Financials

$1B$10B
imed's revenue is estimated to be in the range of $1B$10B

Funding & Financials

$1B$10B
imed's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to imed

Medesk

Practice Better

Vagaro

Mindbody

SimplyBook.me

iClinic

Acuity Scheduling

TheraNest

SimplePractice

Jane App

Fresha

imed Tech Stack

Media & News

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

imed's Email Address Formats

Frequently Asked Questions

Where is imed's headquarters located?

What is imed's stock symbol?

What is imed's official website and social media links?

What is imed's NAICS code?

How many employees does imed have currently?

What industry does imed belong to?

What technology does imed use?

What is imed's email format?

When was imed founded?

imed

Company Overview

Media & News

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?